INL Cluster

A Fully Integrated Magnetoresistive Biochip Platform for Stroke Patient Stratification

In Ischemic stroke patients, the elevated levels of several biomarkers in blood have been shown to accurately predict a high risk of developing negative side effects associated with thrombolytic therapy (hemorrhagic transformation). Diagnostic/ prognostic devices addressing complex diseases need to look for multiple, rather than single, biomarkers to provide actionable information for stratification of patients and personalized medicine. Therefore, this project aims to develop a portable and fully integrated detection system, i.e, a microfluidic unit for sample preparation/purification, integrated to a magnetoresistive biochip platform for stroke patient stratification. A rapid and an accurate diagnosis will increase the number of patients that can benefit from the thrombolytic therapy, and will avoid some expensive and time-consuming exams, improving the sustainability and efficiency of our social and healthcare systems.

Total Eligible Budget

239,719.48 €

INL Eligible Budget

170,456.93 €

Total Funding

239,719.48 €

INL Funding

170,456.93 €

Start Date


End Date


Type of action

SAICT – Projetos de investigação cientifica e desenvolvimento tecnológico (IC&DT)

Grant Agreement Id


Funding Agency


Funding Framework


INL Role


Approval Date


Intervention Region

North of Portugal, Lisbon